tocilizumab in the United States
33 medicine records from 10 holders carry this name in the official sources. Collected on November 10, 2026.
Medicines
| Name | Holder | Code |
|---|---|---|
| ACTEMRA INJECTION, SOLUTION, CONCENTRATE | Genentech, Inc. |
Product NDC
50242-135Package NDC
50242-135-01
|
| ACTEMRA INJECTION, SOLUTION, CONCENTRATE | Genentech, Inc. |
Product NDC
50242-136Package NDC
50242-136-01
|
| ACTEMRA INJECTION, SOLUTION, CONCENTRATE | Genentech, Inc. |
Product NDC
50242-137Package NDC
50242-137-01
|
| Actemra INJECTION, SOLUTION | Genentech, Inc. |
Product NDC
50242-138Package NDC
50242-138-01
|
| Actemra ACTPen INJECTION, SOLUTION | Genentech, Inc. |
Product NDC
50242-143Package NDC
50242-143-01
|
| AVTOZMA INJECTION, SOLUTION | CELLTRION USA, Inc. |
Product NDC
72606-042Package NDC
72606-042-01
|
| AVTOZMA INJECTION, SOLUTION | CELLTRION USA, Inc. |
Product NDC
72606-043Package NDC
72606-043-01
|
| AVTOZMA INJECTION, SOLUTION | CELLTRION USA, Inc. |
Product NDC
72606-044Package NDC
72606-044-01
|
| AVTOZMA INJECTION, SOLUTION | CELLTRION USA, Inc. |
Product NDC
72606-045Package NDC
72606-045-01
|
| tocilizumab LIQUID | Novartis Pharmaceuticals Corporation |
Product NDC
0078-1343Package NDC
0078-1343-09
|
| Tocilizumab LIQUID | Genentech, Inc. |
Product NDC
50242-139Package NDC
50242-139-04
|
| Tocilizumab LIQUID | Genentech, Inc. (SSF) |
Product NDC
50242-141Package NDC
50242-141-04
|
| Tocilizumab LIQUID | Chugai Pharmaceutical Co., Ltd. |
Product NDC
60422-202Package NDC
60422-202-01
|
| Tocilizumab INJECTION, SOLUTION | Chugai Pharmaceutical Co., Ltd. |
Product NDC
60422-220Package NDC
60422-220-01
|
| Tocilizumab INJECTION, SOLUTION, CONCENTRATE | Chugai Pharmaceutical Co., Ltd. |
Product NDC
60422-230Package NDC
60422-230-01
|
| Tocilizumab INJECTION, SOLUTION, CONCENTRATE | Chugai Pharmaceutical Co., Ltd. |
Product NDC
60422-240Package NDC
60422-240-01
|
| Tocilizumab INJECTION, SOLUTION, CONCENTRATE | Chugai Pharmaceutical Co., Ltd. |
Product NDC
60422-250Package NDC
60422-250-01
|
| tocilizumab LIQUID | Lonza Biologics, Inc. |
Product NDC
67643-7007Package NDC
67643-7007-1
|
| Tocilizumab LIQUID | Lonza Biologics, Inc. |
Product NDC
67643-7008Package NDC
67643-7008-1
|
| tocilizumab LIQUID | SAMSUNG BIOLOGICS Co., Ltd. |
Product NDC
71124-0019Package NDC
71124-0019-0
|
| Tofidence INJECTION | Biogen MA Inc |
Product NDC
64406-022Package NDC
64406-022-01
|
| Tofidence INJECTION | Biogen MA Inc |
Product NDC
64406-023Package NDC
64406-023-01
|
| Tofidence INJECTION | Biogen MA Inc |
Product NDC
64406-024Package NDC
64406-024-01
|
| TOFIDENCE INJECTION | Organon LLC |
Product NDC
78206-200Package NDC
78206-200-01
|
| TOFIDENCE INJECTION | Organon LLC |
Product NDC
78206-201Package NDC
78206-201-01
|
| TOFIDENCE INJECTION | Organon LLC |
Product NDC
78206-202Package NDC
78206-202-01
|
| TYENNE INJECTION, SOLUTION | Fresenius Kabi USA, LLC |
Product NDC
65219-584Package NDC
65219-584-01
|
| TYENNE INJECTION, SOLUTION | Fresenius Kabi USA, LLC |
Product NDC
65219-586Package NDC
65219-586-04
|
| TYENNE INJECTION, SOLUTION, CONCENTRATE | Fresenius Kabi USA, LLC |
Product NDC
65219-590Package NDC
65219-590-04
|
| TYENNE INJECTION, SOLUTION, CONCENTRATE | Fresenius Kabi USA, LLC |
Product NDC
65219-592Package NDC
65219-592-10
|
| TYENNE INJECTION, SOLUTION, CONCENTRATE | Fresenius Kabi USA, LLC |
Product NDC
65219-594Package NDC
65219-594-20
|
| TYENNE INJECTION, SOLUTION | Fresenius Kabi USA, LLC |
Product NDC
65219-596Package NDC
65219-596-01
|
| TYENNE INJECTION, SOLUTION | Fresenius Kabi USA, LLC |
Product NDC
65219-598Package NDC
65219-598-10
|
Need this list in your own system?
Every record on this page is available through the API, with its source, licence and retrieval date.